<SEC-DOCUMENT>0001437749-23-022895.txt : 20230810
<SEC-HEADER>0001437749-23-022895.hdr.sgml : 20230810
<ACCEPTANCE-DATETIME>20230810094502
ACCESSION NUMBER:		0001437749-23-022895
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230809
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230810
DATE AS OF CHANGE:		20230810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GeoVax Labs, Inc.
		CENTRAL INDEX KEY:			0000832489
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870455038
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39563
		FILM NUMBER:		231157602

	BUSINESS ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			GA
		ZIP:			30080
		BUSINESS PHONE:		678-384-7220

	MAIL ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			GA
		ZIP:			30080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Geovax Labs, Inc.
		DATE OF NAME CHANGE:	20061002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAUPHIN TECHNOLOGY INC
		DATE OF NAME CHANGE:	19940826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUCCESSO INC
		DATE OF NAME CHANGE:	19910410
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>govx20230809_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:govx="http://www.govx.com/20230809"><head>
	<title>govx20230809_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 8/9/2023 5:12:57 PM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20238K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20238K" name="dei:EntityCentralIndexKey">0000832489</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="govx-20230809.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20238K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000832489</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-08-09</xbrli:startDate>
<xbrli:endDate>2023-08-09</xbrli:endDate>
</xbrli:period>
</xbrli:context>

<xbrli:context id="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000832489</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">govx:CommonStockParValue0001PerShareCustomMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-08-09</xbrli:startDate>
<xbrli:endDate>2023-08-09</xbrli:endDate>
</xbrli:period>
</xbrli:context>

<xbrli:context id="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000832489</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">govx:WarrantsToPurchaseCommonStockCustomMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-08-09</xbrli:startDate>
<xbrli:endDate>2023-08-09</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 18pt; font-variant: normal; text-align: center; margin: 0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>WASHINGTON, D.C. 20549</b>&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 15%; border: none; margin: 0pt auto 0pt auto;" />
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 18pt; font-variant: normal; text-align: center; margin: 0pt;"><b>FORM <ix:nonNumeric contextRef="d20238K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Pursuant to Section 13 or 15(d) of the</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Securities Exchange Act of 1934</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Date of report (Date of earliest event reported):</b>&#xa0;&#xa0;<ix:nonNumeric contextRef="d20238K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><b>August 9, 2023</b></ix:nonNumeric></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#xa0;</div>

<hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 15%; border: none; margin: 0pt auto 0pt auto;" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 18pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityRegistrantName"><b>GEOVAX LABS, INC.</b></ix:nonNumeric></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(Exact name of registrant as specified in its charter)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b>Delaware</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align: bottom; width: 2%;">&#xa0;</td>
			<td style="vertical-align: top; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityFileNumber"><b>001-39563</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align: bottom; width: 2%;">&#xa0;</td>
			<td style="vertical-align: top; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityTaxIdentificationNumber"><b>87-0455038</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(State or other jurisdiction of</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>incorporation or organization)</b></div>
			</td>
			<td style="vertical-align: bottom; width: 2%;">&#xa0;</td>
			<td style="vertical-align: top; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Commission File No.)</b></div>
			</td>
			<td style="vertical-align: bottom; width: 2%;">&#xa0;</td>
			<td style="vertical-align: top; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(IRS Employee Identification No.)</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressAddressLine1"><b>1900 Lake Park Drive, Suite 380</b></ix:nonNumeric></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressCityOrTown"><b>Smyrna</b></ix:nonNumeric><b>, <ix:nonNumeric contextRef="d20238K" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince"><b>Georgia</b></ix:nonNumeric> <ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressPostalZipCode"><b>30080</b></ix:nonNumeric></b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(Address of principal executive offices) (Zip code)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(<ix:nonNumeric contextRef="d20238K" name="dei:CityAreaCode"><b>678</b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20238K" name="dei:LocalPhoneNumber"><b>384-7220</b></ix:nonNumeric></b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(Registrant</b>&#8217;<b>s telephone number, including area code)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR240.14a-12)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13(e)-4(c))</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:18.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Title of each class</div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Trading</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Symbol(s)</div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:18.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Name of each exchange on which registered</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:18.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:8.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare" name="dei:TradingSymbol">GOVX</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:18.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The <ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> Capital Market</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:18.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock" name="dei:Security12bTitle">Warrants to Purchase Common Stock</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:8.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock" name="dei:TradingSymbol">GOVXW</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:18.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The <ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> Capital Market</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Emerging growth company <ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial reporting standards provided pursuant to Section&#xa0;13(a) of the Exchange Act. &#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
1

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Forward-Looking Statements</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">This Current Report on Form 8-K and other reports filed by the Company from time to time with the Securities and Exchange Commission (collectively the &#8220;Filings&#8221;) contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company&#8217;s management as well as estimates and assumptions made by the Company&#8217;s management. When used in the Filings the words &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;estimate&#8221;, &#8220;expect&#8221;, &#8220;future&#8221;, &#8220;intend&#8221;, &#8220;plan&#8221; or the negative of these terms and similar expressions as they relate to the Company or the Company&#8217;s management identify forward looking statements.&#xa0;&#xa0;Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to the Company&#8217;s industry, operations and results of operations and any businesses that may be acquired by the Company. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned. Except as required by law, the Company does not undertake to update its forward-looking statements.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 63pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Item 2.02 </b></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Results of Operations and Financial Condition.</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On August 9, 2023, GeoVax Labs, Inc. (the &#8220;Company&#8221;) issued a press release reporting its results of operations for the quarter ended June 30, 2023. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 63pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Item 9.01 </b></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Financial Statements and Exhibits.</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">(d)&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;Exhibits</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:5.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;"><span style="text-decoration: underline;">Exhibit No.</span></div>
			</td>
			<td style="vertical-align:top;width:40.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline;">Description</span></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:5.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">99.1</div>
			</td>
			<td style="vertical-align:top;width:40.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_557810.htm" style="-sec-extract:exhibit;">Press Release dated August 9, 2023</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:5.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">104</div>
			</td>
			<td style="vertical-align:top;width:40.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
2

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>SIGNATURE</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Date: August 10, 2023</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td colspan="2" style="vertical-align: top; width: 3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">GEOVAX LABS, INC.</div>
			</td>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td colspan="2" style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td colspan="2" style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 35%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Mark W. Reynolds</div>
			</td>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 35%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mark W. Reynolds</div>
			</td>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 35%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Financial Officer</div>
			</td>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 35%;">&#xa0;</td>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
3
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_557810.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_557810.htm</title>

	<!-- Generated by ThunderDome Portal - 8/9/2023 5:33:45 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<div><img alt="logo01.jpg" src="logo01.jpg"></div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>GeoVax Reports 2023 Second Quarter Financial Results</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>and Provides Corporate Update</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>Progress and Promising Outlook for Gedeptin</i></b>&#174;<b><i> and GEO-CM04S1</i></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>Phase 2 GEO-CM04S1 Clinical Trial Initiated for Patients with Chronic Lymphocytic Leukemia</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><b><i>Company to Host Conference Call and Webcast Today at 4:30 p.m. ET</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Atlanta, GA, August 9, 2023 </b>&#8211; GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, today announced its financial results for the quarter ended June 30, 2023, and recent corporate highlights.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">David Dodd, GeoVax&#8217;s Chairman and CEO, commented, &#8220;The first half of 2023 has been highly productive for GeoVax, with continued enrollment in, and positive interim clinical data presented for, both of our lead programs, Gedeptin&#174;<sup style="vertical-align:top;line-height:120%;"> </sup>and GEO-CM04S1. We are also excited to have recently announced the start of an important third Phase 2 clinical study for GEO-CM04S1, in patients with chronic lymphocytic leukemia. Our next-generation COVID-19 vaccine, which utilizes an MVA-vector containing the two antigens, S and N, induces broad and durable antibody and cellular immune responses that we believe has the potential to offer a more robust, durable degree of protection than the current authorized COVID-19 vaccines, particularly in highly vulnerable immunocompromised patients.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Mr. Dodd continued, &#8220;In addition to clinical progress, there are other notable achievements that set the stage for our future success. We have made significant progress in developing a high-yield, high-capacity, continuous avian cell line system for manufacturing our MVA-based vaccines and immunotherapies, and we recently partnered with Advanced Bioscience Laboratories, Inc. to support current Good Manufacturing Practices production of our MVA-based products through late-stage development and eventual commercialization. Additionally, the recent expansion of our GEO-CM04S1 rights to include development for Mpox and smallpox adds to other rights we previously secured from the NIH covering preclinical, clinical, and commercial uses of the NIH-MVA. This provides a compelling opportunity to leverage our MVA-based vaccine expertise and help expand the global public health supply options available for the worldwide public health threats posed by SARS-CoV-2, Mpox and smallpox. We expect significant clinical developments and other important events during the remainder of 2023, and we look forward to continuing to share news of our progress.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Recent Business Highlights:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>New Clinical Trial Initiated for GEO-CM04S1</b>. In July, GeoVax announced the start of a Phase 2 COVID-19 vaccine booster investigator-initiated clinical trial (ClinicalTrials.gov Identifier: <u>NCT05672355</u>) in patients with chronic lymphocytic leukemia (CLL), a recognized high-risk group for whom current mRNA vaccines and monoclonal antibody (MAb) therapies appear inadequate relative to providing protective immunity. As a result of their medical status, CLL patients are largely unable to mount a sufficient antibody response to the mRNA vaccines. The trial is expected to enroll approximately 80 patients, comparing GEO-CM04S1 vs the Pfizer/BioNTech Bivalent vaccine. Completion of patient enrollment is expected within approximately six months. This investigator-initiated trial is being primarily funded by a private family foundation with GeoVax supporting the analysis of samples, so it is expected to have minimal impact on the Company&#8217;s balance sheet.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Gedeptin</b>&#174;<b>&nbsp;Clinical Trial Data.</b>&nbsp;Interim data from the Phase 1/2 clinical trial of Gedeptin&#174;&nbsp;was presented at the American Association for Cancer Research (AACR) and the American Head and Neck Society (AHNS) joint Head and Neck Cancer Conference in July. The ongoing Phase 1/2 trial (ClinicalTrials.gov Identifier: <u>NCT03754933</u>) is evaluating the safety and efficacy of repeat cycles of Gedeptin therapy in patients with recurrent head and neck cancers whose tumor(s) are accessible for injection, and who have no curable treatment options. The poster presentation, which can be viewed here, highlighted data from 8 patients enrolled in the study to date, noting no dose-limiting toxicities or serious adverse events definitively attributable to treatment, with impairment of tumor growth in targeted lesions observed in 5 of 7 patients (one patient remaining under study).</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 18pt;">The study is being funded in part by the U.S. Food and Drug Administration (FDA) pursuant to its Orphan Products Clinical Trials Grants Program. The FDA has also granted Gedeptin<sup style="vertical-align:top;line-height:120%;"> </sup>orphan drug status for the intra-tumoral treatment of anatomically accessible oral and pharyngeal cancers, including cancers of the lip, tongue, gum, floor of the mouth, salivary gland, and other oral cavities. GeoVax expects to complete the current trial by year-end 2023, after which expanded development of Gedeptin is anticipated, both as monotherapy and combination therapy in conjunction with other therapies to potentially include immune checkpoint inhibitors, angiogenesis inhibitors, radiation, chemotherapy, etc.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>MORE</b></p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>GEO-CM04S1 Clinical Trial Data</b>. In April, unpublished data from the open-label portion of the Phase 2 trial of GEO-CM04S1 in patients with hematologic cancers receiving cell transplants or CAR-T therapy (ClinicalTrials.gov Identifier: <u>NCT04977024</u>) was presented during the 23<sup style="vertical-align:top;line-height:120%;">rd</sup>&nbsp;Annual World Vaccine Congress. This trial is investigating GEO-CM04S1 in a profoundly immunosuppressed patient population due to their pre-transplant induction regimens. The preliminary analysis indicates GEO-CM04S1 is highly immunogenic in these patients, inducing both neutralizing antibodies and T cell responses, which the Company believes are important to confer protection against severe COVID-19. These data support the planned progression of the Phase 2 clinical study, which will include a direct comparison to currently approved mRNA vaccines and is anticipated to include multiple sites both within and outside the U.S.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 18pt;">Further underscoring the need for next-generation COVID-19 vaccines such as GEO-CM04S1, GeoVax scientists co-authored an article titled, &#8220;<i>MVA-Vectored Universal Beta-Coronavirus Vaccine Design &amp; Development</i>&#8221;, published in the June 2023 issue of the online journal <i>Vaccine Insights</i>. The article, accessible here, provides expert insight into the emergence of SARS-CoV-2 (COVID-19), the risk of new &#8220;spillover events&#8221; from animal hosts, and how this risk can be addressed proactively. Regarding COVID-19 and its continually evolving variants, the authors describe the limitations of first-generation vaccines and the potential for MVA-vectored vaccines such as GEO-CM04S1 to overcome these limitations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Mpox Vaccine Rights Added to GEO-CM04S1</b>. In April, GeoVax expanded its rights under its license agreement with City of Hope&nbsp;(COH) for GEO-CM04S1, which now grants GeoVax development and commercialization rights against orthopoxviruses in addition to SARS-CoV-2. Orthopoxviruses include Mpox, smallpox, and other viruses that cause disease in humans. GEO-CM04S1, which can induce strong antibody and T cell responses against the SARS-CoV-2 virus variants, also offers the possibility of protection against Mpox and smallpox diseases, further differentiating GEO-CM04S1 as compared to current mRNA-based COVID-19 vaccines. Such attributes may be especially important in vulnerable patient populations, such as the immune-compromised, and in geographic areas where both diseases are endemic. Such a vaccine may offer a simplified vaccine regimen for protection against diseases associated with SARS-CoV-2 and orthopoxviruses.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>GEO-MVA (Mpox and smallpox vaccine).</b>&nbsp;Following the recent announcement of GeoVax acquiring the rights from NIH to develop, manufacture and commercialize MVA as a vaccine against Mpox and smallpox, the Company has advanced to active regulatory discussions related to an expedited regulatory path for registration. GeoVax is focused on being the first U.S. supplier of the vaccine, providing expanded supply options for public health worldwide.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Manufacturing Development Progress</b>. In May, GeoVax announced it had entered into an agreement with Advanced Bioscience Laboratories, Inc. (ABL) to support current Good Manufacturing Practices (cGMP) production of the company&#8217;s vaccine candidates, including GEO-CM04S1. ABL, a subsidiary of Institut M&#233;rieux, is a pure-play contract development and manufacturing organization (CDMO) specialized in the development and manufacturing of gene therapies, oncolytic viruses, and vaccine candidates. With cGMP facilities in the U.S. and Europe, ABL is well-positioned to support GeoVax&#8217;s global development programs through late-stage development and eventual commercialization.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 18pt;">Earlier in 2023, GeoVax announced significant progress in developing a high-yield, high-capacity, continuous avian cell line system for manufacturing its MVA-based vaccines and immunotherapies. The Company is accelerating activities towards fully implementing a proprietary, continuous cell line manufacturing system that will provide lower-cost, scalable versatility for broad MVA vaccine and immunotherapy applications. GeoVax is on course to expand MVA applications from stockpile-based solutions for niche medical markets to have the capability to respond to large-scale worldwide requirements on a timely basis.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>MORE</b></p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Preclinical Programs</b>. Data from recent nonhuman primate studies of GEO-MM01 against Marburg virus were presented during the 23<sup style="vertical-align:top;line-height:120%;">rd</sup>&nbsp;Annual World Vaccine Congress. Of particular interest, immunization with GEO-MM01 conferred 80% survival in cynomolgus macaques following a lethal dose of Marburg virus. Vaccination protected nonhuman primates from viremia, weight loss, and death following challenge with a lethal Marburg virus dose. Evaluation of immune responses following vaccination demonstrated the presence of both neutralizing antibodies and functional T cells, indicating a breadth of response capable of offering significant protection.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Patent Portfolio Development</b>. In July, GeoVax announced that the U.S. Patent and Trademark Office issued Patent No. 11,701,418 B2 to GeoVax, pursuant to the Company&#8217;s patent application No. 15/543,139 titled &#8220;<i>Replication-Deficient Modified Vaccinia Ankara (MVA) and Matrix Protein (VP40).</i>&#8221;<i>&nbsp;</i>The claims granted by the patent generally cover GeoVax&#8217;s vector platform for expressing ebolavirus antigens in virus-like particles (VLPs) utilizing an MVA viral vector. The claims encompass multiple ebolavirus strains, including Sudan ebolavirus, Zaire ebolavirus, Ta&#239;&nbsp;Forest ebolavirus, and Reston ebolavirus. GeoVax previously demonstrated that a single intramuscular (IM) dose of its vaccine candidate, GEO-EM01, provided 100% protection in rhesus macaques challenged with a lethal dose of Zaire ebolavirus (EBOV). Additionally, the Company&#8217;s preclinical efficacy studies of its Sudan ebolavirus (SUDV) vaccine candidate demonstrated that a single dose of the vaccine protected 100% of small animals challenged with a lethal dose of SUDV.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 18pt;">Earlier in 2023, GeoVax announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for Patent Application No. 17/000,768 titled, &#8220;<i>Method for Generating a ZIKV Immune Response Utilizing a Recombinant Modified Vaccinia Ankara Vector Encoding the NS1 Protein</i>.&#8221; Preclinical studies demonstrated that a single dose of GEO-ZM02 provided 100% protection against a lethal dose of the Zika virus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 18pt;">These patents add to the Company&#8217;s growing portfolio of wholly owned, co-owned, and in-licensed intellectual property, now standing at over 115 granted or pending patent applications spread over 24 patent families.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Financial Results</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Net Loss</b>: Net loss for the three months ended June 30, 2023, was $5,927,620, or $0.22 per share, as compared to $2,241,699, or $0.18 per share, for the comparable period in 2022. For the six months ended June 30, 2023, the Company&#8217;s net loss was $9,965,536 ($0.38 per share) as compared to a net loss of $4,669,214 ($0.47 per share) in 2022.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>R&amp;D Expenses</b>: Research and development expenses were $4,719,728 and $7,538,917 for the three-month and six-month periods ended June 30, 2023, compared to $1,307,177 and $2,637,721 for the comparable periods in 2022, with the increases primarily due to the cost of conducting clinical trials for GEO-CM04S1 and Gedeptin, costs of manufacturing materials for use in our clinical trials, additional personnel costs, technology license fees, costs of preclinical research activities and a generally higher level of activity.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>G&amp;A Expenses</b>: General and administrative expenses were $1,459,093 and $2,910,518 for the three-month and six-month periods ended June 30, 2023, compared to $935,311 and $2,114,335 for the comparable periods in 2022, with the increases primarily due to higher personnel costs, investor relations consulting costs, patent costs and other expenses supportive of a higher level of activity.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Cash Position</b>: GeoVax reported cash balances of $17,788,911 at June 30, 2023, as compared to $27,612,732 at December 31, 2022.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Summarized financial information is included. Further information is included in the Company&#8217;s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Conference Call Details</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Management will host a conference call scheduled to begin at 4:30 p.m. ET today, August 9, 2023, to review financial results and provide an update on corporate developments. A question-and-answer session will follow management&#8217;s formal remarks.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 17%;">Domestic:</td>
			<td style="width: 83%;">800-715-9871</td>
		</tr>
		<tr>
			<td style="width: 17%;">International:</td>
			<td style="width: 83%;">646-307-1963</td>
		</tr>
		<tr>
			<td style="width: 17%;">Conference ID:</td>
			<td style="width: 83%;">5604173</td>
		</tr>
		<tr>
			<td style="width: 17%;">Webcast:</td>
			<td style="width: 83%;"><u>GeoVax Earnings Webcast</u></td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A webcast replay of the call will be available for three months via the same link as the live webcast approximately two hours after the end of the call.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>MORE</b></p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>About GeoVax</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel therapies and vaccines for solid tumor cancers and many of the world&#8217;s most threatening infectious diseases. The company&#8217;s lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin&#174;, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax&#8217;s lead infectious disease candidate is GEO-CM04S1, a next-generation COVID-19 vaccine targeting high-risk immunocompromised patient populations. Currently in three Phase 2 clinical trials, GEO-CM04S1 is being evaluated as a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, and as a booster vaccine in patients with chronic lymphocytic leukemia (CLL). In addition, GEO-CM04S1 is in a Phase 2 clinical trial evaluating the vaccine as a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. GeoVax has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information, visit our website: www.geovax.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Forward-Looking Statements</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>This release contains forward-looking statements regarding GeoVax</i>&#8217;<i>s business plans. The words </i>&#8220;<i>believe,</i>&#8221;<i> </i>&#8220;<i>look forward to,</i>&#8221;<i> </i>&#8220;<i>may,</i>&#8221;<i> </i>&#8220;<i>estimate,</i>&#8221;<i> </i>&#8220;<i>continue,</i>&#8221;<i> </i>&#8220;<i>anticipate,</i>&#8221;<i> </i>&#8220;<i>intend,</i>&#8221;<i> </i>&#8220;<i>should,</i>&#8221;<i> </i>&#8220;<i>plan,</i>&#8221;<i> </i>&#8220;<i>could,</i>&#8221;<i> </i>&#8220;<i>target,</i>&#8221;<i> </i>&#8220;<i>potential,</i>&#8221;<i> </i>&#8220;<i>is likely,</i>&#8221;<i> </i>&#8220;<i>will,</i>&#8221;<i> </i>&#8220;<i>expect</i>&#8221;<i> and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax</i>&#8217;<i>s immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax</i>&#8217;<i>s viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax</i>&#8217;<i>s immuno-oncology products and preventative vaccines will be safe for human use, GeoVax</i>&#8217;<i>s vaccines will effectively prevent targeted infections in humans, GeoVax</i>&#8217;<i>s immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax</i>&#8217;<i>s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. </i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.</i>&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Investor Relations Contact:</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Rich Cockrell</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CG Capital</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">404-736-3838</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>govx@cg.capital</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>FINANCIAL TABLES FOLLOW</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>MORE</b></p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td colspan="8" style="vertical-align:top;width:100.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>GEOVAX LABS, INC.</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="8" style="vertical-align:top;width:100.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Condensed Consolidated Statements of Operations Information</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="8" style="vertical-align:top;width:100.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(amounts in thousands, except common share information</i></p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="6" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Three Months Ended</p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="6" id=".amt.D5" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Six Months Ended</p>
			</td>
			<td id=".trail.D5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="6" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">June 30,</p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="6" id=".amt.D5" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">June 30,</p>
			</td>
			<td id=".trail.D5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="2" id=".amt.D4" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
			<td id=".trail.D4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="2" id=".amt.D5" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td id=".trail.D5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 52%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Grant and collaboration revenue</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">82</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1">&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
			<td id=".lead.B5">&nbsp;</td>
			<td id=".symb.B5">&nbsp;</td>
			<td id=".amt.B5">&nbsp;</td>
			<td id=".trail.B5">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating expenses:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Research and development</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,720</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,307</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7,539</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,638</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">General and administrative</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,459</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">935</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,910</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,114</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">6,179</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,242</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">10,449</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,752</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Loss from operations</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(6,179</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(2,242</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(10,449</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(4,670</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Interest income</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">251</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">484</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1">&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
			<td id=".lead.B5">&nbsp;</td>
			<td id=".symb.B5">&nbsp;</td>
			<td id=".amt.B5">&nbsp;</td>
			<td id=".trail.B5">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net loss</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(5,928</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(2,242</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(9,965</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(4,669</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1">&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
			<td id=".lead.B5">&nbsp;</td>
			<td id=".symb.B5">&nbsp;</td>
			<td id=".amt.B5">&nbsp;</td>
			<td id=".trail.B5">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Loss per common share</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.22</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.18</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.38</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.47</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td colspan="8" style="vertical-align:top;width:100.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Condensed Consolidated Balance Sheet Information</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="8" style="vertical-align:top;width:100.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(amounts in thousands, except common share information)</i></p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">June 30,</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Dec. 31,</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 70%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Assets:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Cash and cash equivalents</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">17,789</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">27,613</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Other current assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,038</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,326</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total current assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">19,827</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">28,939</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Property and other assets, net</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,422</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,409</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">21,249</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">31,348</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1">&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Liabilities and stockholders&#8217; equity</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,085</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,748</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Stockholders&#8217; equity</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">17,164</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">26,600</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total liabilities and stockholders&#8217; equity</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">21,249</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">31,348</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1">&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Common shares outstanding</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">26,443,649</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">26,334,953</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>###</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>govx-20230809.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 8/9/2023 5:13:05 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:govx="http://www.govx.com/20230809" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.govx.com/20230809">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="govx-20230809_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="govx-20230809_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="govx-20230809_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.govx.com/20230809/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="govx_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="govx_CommonStockParValue0001PerShareCustomMember" name="CommonStockParValue0001PerShareCustomMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="govx_WarrantsToPurchaseCommonStockCustomMember" name="WarrantsToPurchaseCommonStockCustomMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>govx-20230809_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 8/9/2023 5:13:05 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.govx.com/20230809/role/statement-document-and-entity-information" xlink:href="govx-20230809.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.govx.com/20230809/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain-default" xlink:type="locator"/>
<link:loc xlink:href="govx-20230809.xsd#govx_CommonStockParValue0001PerShareCustomMember" xlink:label="govx_CommonStockParValue0001PerShareCustomMember" xlink:type="locator"/>
<link:loc xlink:href="govx-20230809.xsd#govx_WarrantsToPurchaseCommonStockCustomMember" xlink:label="govx_WarrantsToPurchaseCommonStockCustomMember" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="govx_CommonStockParValue0001PerShareCustomMember" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="govx_WarrantsToPurchaseCommonStockCustomMember" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>govx-20230809_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 8/9/2023 5:13:05 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
<link:label xlink:label="us-gaap_StatementClassOfStockAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
<link:label xlink:label="us-gaap_ClassOfStockDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain-label" xlink:type="arc"/>

<link:loc xlink:href="govx-20230809.xsd#govx_CommonStockParValue0001PerShareCustomMember" xlink:label="govx_CommonStockParValue0001PerShareCustomMember" xlink:type="locator"/>
<link:label xlink:label="govx_CommonStockParValue0001PerShareCustomMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CommonStockParValue0001PerShare Custom [Member]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CommonStockParValue0001PerShareCustomMember" xlink:to="govx_CommonStockParValue0001PerShareCustomMember-label" xlink:type="arc"/>

<link:loc xlink:href="govx-20230809.xsd#govx_WarrantsToPurchaseCommonStockCustomMember" xlink:label="govx_WarrantsToPurchaseCommonStockCustomMember" xlink:type="locator"/>
<link:label xlink:label="govx_WarrantsToPurchaseCommonStockCustomMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">WarrantsToPurchaseCommonStock Custom [Member]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_WarrantsToPurchaseCommonStockCustomMember" xlink:to="govx_WarrantsToPurchaseCommonStockCustomMember-label" xlink:type="arc"/>


</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>govx-20230809_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 8/9/2023 5:13:05 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.govx.com/20230809/role/statement-document-and-entity-information" xlink:href="govx-20230809.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.govx.com/20230809/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
<link:loc xlink:href="govx-20230809.xsd#govx_CommonStockParValue0001PerShareCustomMember" xlink:label="govx_CommonStockParValue0001PerShareCustomMember" xlink:type="locator"/>
<link:loc xlink:href="govx-20230809.xsd#govx_WarrantsToPurchaseCommonStockCustomMember" xlink:label="govx_WarrantsToPurchaseCommonStockCustomMember" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="govx_CommonStockParValue0001PerShareCustomMember" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="govx_WarrantsToPurchaseCommonStockCustomMember" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>

<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>logo01.jpg
<TEXT>
begin 644 logo01.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_[@ A061O8F4 9$     ! P 0 P(#!@
M             /_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$! 0$!
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\( $0@ -0#' P$1  (1 0,1 ?_$ /$   (# 0$  P$!
M      D*  <(!@4"! L! P$  @,! 0$!            !08 ! <# @@!$
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MZS]-M_(7XKEZL]?BO[W]K/-YB7RS^&C]?>[I7R3Z(_K>N%[][5X%O-TU_]H
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MJ[HQ;O1QM3Y,<K",,;(BZ(NB-D;K)S>1\2PB)P\S#-T3VHF8^5 <6/F+?O\
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MUX_Z7_\ GGQE7_++])>4]S7_ '8]MO=GTAYOVSKT_P";^L?Z5]3^7]3DZ/\
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KG",F8B1; T33N59,C$)P3<YI"1B'=;34(E(A(M8EM3E7IW+%>12;IK?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140330297173584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 09, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">GEOVAX LABS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Aug.  09,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-39563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">87-0455038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">1900 Lake Park Drive, Suite 380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Smyrna<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">30080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">384-7220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0000832489<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=govx_CommonStockParValue0001PerShareCustomMember', window );">CommonStockParValue0001PerShare Custom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GOVX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=govx_WarrantsToPurchaseCommonStockCustomMember', window );">WarrantsToPurchaseCommonStock Custom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to Purchase Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GOVXW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=govx_CommonStockParValue0001PerShareCustomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=govx_CommonStockParValue0001PerShareCustomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=govx_WarrantsToPurchaseCommonStockCustomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=govx_WarrantsToPurchaseCommonStockCustomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>govx20230809_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:govx="http://www.govx.com/20230809"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="govx-20230809.xsd" xlink:type="simple"/>
    <context id="d20238K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
        </entity>
        <period>
            <startDate>2023-08-09</startDate>
            <endDate>2023-08-09</endDate>
        </period>
    </context>
    <context id="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">govx:CommonStockParValue0001PerShareCustomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-09</startDate>
            <endDate>2023-08-09</endDate>
        </period>
    </context>
    <context id="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">govx:WarrantsToPurchaseCommonStockCustomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-09</startDate>
            <endDate>2023-08-09</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20238K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20238K">0000832489</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20238K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20238K">2023-08-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20238K">GEOVAX LABS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20238K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20238K">001-39563</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20238K">87-0455038</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20238K">1900 Lake Park Drive, Suite 380</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20238K">Smyrna</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20238K">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20238K">30080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20238K">678</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20238K">384-7220</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20238K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20238K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20238K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20238K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare">GOVX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock">Warrants to Purchase Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock">GOVXW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20238K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%
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MN)%LEDO:0#_3"0W8>0TB63/UQFJ#7WYRV\[O"+"? _N8^F!CQ#IY9 NNC:*
M?D]C5H:)"]U</3P-OY+;X<6T3L;WHU,$KIG#-5'-G37K9+9.2IGP^=V3+PA%
M*Z=H'4DQ88I+&W@A@? M!<*ELG#+XJTJX-HY7/LH_XU%(%4B519Q=3(UP$>D
M(B.9"J/6\!F6\N+JEU<(8B='[!R%>,TC1N[3^(6I,A)<Q''<$[_7:F,VZ^9
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M> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( *!-"E>7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ H$T*5SJJHN=  0
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M?P%02P$"% ,4    " "@30I7!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( *!-"E<3]=5\\    "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( *!-"E>97)PC$ 8  )PG   3              "  <X!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ H$T*5\ZUJ\KM!   =!4  !@
M         ("!#P@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( *!-"E>?H!OPL0(  .(,   -              "  3(-  !X;"]S='EL
M97,N>&UL4$L! A0#%     @ H$T*5Y>*NQS     $P(   L
M ( !#A   %]R96QS+RYR96QS4$L! A0#%     @ H$T*5SJJHN=  0  / (
M  \              ( !]Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M *!-"E<D'INBK0   /@!   :              "  602  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( *!-"E=ED'F2&0$  ,\#   3
M              "  4D3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )
-  D /@(  ),4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="govx20230809_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.govx.com/20230809/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="govx20230809_8k.htm">govx20230809_8k.htm</File>
    <File>ex_557810.htm</File>
    <File>govx-20230809.xsd</File>
    <File>govx-20230809_def.xml</File>
    <File>govx-20230809_lab.xml</File>
    <File>govx-20230809_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "govx20230809_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 25
   },
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "govx-20230809_def.xml"
     ]
    },
    "inline": {
     "local": [
      "govx20230809_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "govx-20230809_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "govx-20230809_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "govx-20230809.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    }
   },
   "elementCount": 30,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "govx",
   "nsuri": "http://www.govx.com/20230809",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "govx20230809_8k.htm",
      "contextRef": "d20238K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.govx.com/20230809/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "govx20230809_8k.htm",
      "contextRef": "d20238K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document, Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "govx_CommonStockParValue0001PerShareCustomMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CommonStockParValue0001PerShare Custom [Member]"
       }
      }
     },
     "localname": "CommonStockParValue0001PerShareCustomMember",
     "nsuri": "http://www.govx.com/20230809",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "govx_WarrantsToPurchaseCommonStockCustomMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WarrantsToPurchaseCommonStock Custom [Member]"
       }
      }
     },
     "localname": "WarrantsToPurchaseCommonStockCustomMember",
     "nsuri": "http://www.govx.com/20230809",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.govx.com/20230809/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001437749-23-022895-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-23-022895-xbrl.zip
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M9=8FNGA(#[DY^BN)8G4]&N\49J@5^_" ZXCW+4>TDBXT$_L."TC>.7NU:O5
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MZUGZ>#I-MIS14'*!KV)O%WO[A?;VL1OUQ+G)Y+(;F]Q,(=W'@&7CL(FIAL5
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M79="?3O](19.$N?O/_UYEO4&+:#=K!] Q>NV]D8P[%[<]X_^'U!+ P04
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M*:98 _OJYP:KJ1:B9DT"EA)4M-\+280%!U,FME,N(- $_!!P,KZ^2(RQGC3
MS_?)@'?O5@5!8R!MU_1XS83HJ,OXGCW*8Y+N9!=G=+>9F=[;;(S0F$ *NSQH
M>0R5+T)/N9:P8WD +XAI'Z:(K.>PL\1IY R(@BTW4MUG6&K_<<%,!L Q"^]I
M>*<B0P:E5%RA:_()IEA(CJC\AJ(T:EFP0IGU5,[,YXPGKCS4(;7+8BKYJLM"
M,U&K5H7R_HP)?(OWTZ8#DH>00AF-T+(7ZMUG@M?9= Z]''RA7#MAR$&(S9>.
M8'4CSPQL&1R[ZO*1C]C"O*49D67P2[S_D0\X>\7KUZI,D@9X&4P'3*5,Y%\\
MSUS:6>""6.J)ZW! !EYICXO:8U6'9#!CU!Q;3)""&/W@6*J$M<NB**:;0)&V
M]V?B"N(V9 0'*GVGTP?EU!PCDD+,#"J(U8"#M@*HU97D'SK;YX^32>ILYH/+
M8=D3(@9^%%=CDZ)F&X)8.=FJ?CT>89F:PYL@!3$:<:2/^X:K:,S27"_U><'6
MN5\&,T2G8,CSLF"%[@'W$?"I,L87SA9RIOQHCNC*N EDH@OBV5%.'6K'_DS0
M-(59ZO-";=95@W%$>FJ%+;^"V5H&W$G<)DB,DT.B6'A3A.9K@D"DV-YY8[JY
M\3S<GH1T"1+B<3*4+'A)>4>TQI?&?)] ZKE%/O#_P/74TY;#DS=]YUGO OJU
M2_4_0/QO1&*HU6IU]5H[G"&U2<1"LN@!4A*84YN?2?@'XOJE5HS8(.8J\ G8
MXY!']^C&)K)OIXT='CB,JWVS[=94J^0DMA40)B!LNY+'NY"\.>0]_91]PEF4
M?3C#\HX)U1!Y(NH7%_'>7T]2D>[T%FJNRY@2^UC([*.0A;A&*5-U(7794UC&
MNLHHX[PY9>[1,;,X'RUOF5U,TY'[>9GSEEK8?.^;&8N)G;M3E1@S+R+TQ#WN
MO!G=W&14PE+>D\2#VJZ J;XXVA![=?9,+^X?E$O8,06@2LSLJ=(.:R$E;H>7
MEY-11REQ)[R<KOPBC(6L/RHJZXB2C87*FXJJ--5\+"3]65%)5G4B"WU_551?
M;GW)0MMMM;69*E,6RIK55I99SK+9JXO/-\_2EU$&LU%7O53$7$RST5.]7"2[
M'&>CJ7IYB$4MST98]3*1O%J@C:KJ91ZV-40;==5+0HZK.MIHK%XBDEVWM-%4
MO00DH_AI(ZAZ>4=^Z=3F9;JJ^89%Q=5&7O42CHRRK8V@ZF4<%C7?O7,Y_R=M
MJMN7C[O[^D/_74;=^0]02P,$%     @ H$T*5Z"P6"++!@  BT4  !4   !G
M;W9X+3(P,C,P.# Y7VQA8BYX;6S-G&MOVS84AK\/V'_@O"\;4$5V@@YUT+0(
MW+0PEC1&[*S#BJ&@)=H6*ND8%-W8_WXDY9ML4C>;U+XTLG1TWN/W/!*IB_OV
M_3(*T0]"DP#BFU;GHMU")/; #^+I3>MYZ-P.>_U^"R4,QSX.(28WK1A:[]_]
M_-/;7QSG$XD)Q8SX:+Q"H]DB]@G] !%! Z ,A\A!;]RN>]F^O$*OKSM7U^W7
M:/#@.&+O,(B_7XM_QC@AB%<1)_+C36O&V/S:=5]>7BZ68QI> )WR%.TK=Q/=
M6H>+K3[;[K ?_-I--VY#CU*_7,G83K?;=>76;6@2J )YTH[[]\/]T)N1"#M!
M+"SQ1"U)<)W(E??@829]+/P*2!LA/CF;,$>L<CJ7SE7G8IGXK:UQ%$+R1"9(
M_'U^ZFL5NZZ(<&,R%5VZQV,2\HIEBADE$_5^(:69W40575%%YP]1Q:^J;&PU
MYV@D030/2<L]L<X!H0'X=_&9"U:G-5#YD&'*3-1^G/BLU8^ '[3GK?LXY7DK
MYF<N<N:*CU*>M>+/Y,QD'"8\5[4URF3')9:J+10Q]WQI'2;2Y9Q$I=KZE+V7
MEBP9X0/0WEDR!.^H_&0S4B3$NYC"#]<G@1RAQ((C%F3E_,.WNY@%;,7',QS$
M&RE9ZDU+MSFM)!0# =##;YB?P@GWG2IEP;&UE"2PH%XZ1'(E,8J3V'D>MMZE
M6NAKJO;O6W=73+;,6[IQ#5.OH(YUA.L!'POG+/L=)A2B'*N@R(/T*W$):>29
MFGK/CYHPU;Q=!HFBKYJ(BJT]R&*ZNU(.;7HL%.UV6&<:E'##2)\_@+>(2,SZ
M\01H).=E_ Q#^HQ$JJ:7":](0%Y*TSALM-&>./HJY)'4MPM'*7.AJFNVL!GA
M<4C*(9,)/1T7F:X95*1TXY1D_=03HC#**!TCGCR'B/W--2D0*6QU_A42:HWT
M.N,4%%E@M*?;J\,/?%:=TUQE7,TN9W+9:W<JRV<+/A+"C71>;2.4]L<("^D,
MY8E,@X11'+//.%*AD!=6ZPH@F\K.E< KM%-%0K:!*P*-A5#6&X,0]&,/Z!RH
M'%^&C//7@T7,Z*H'OIZ)4GO50B0WLRUB,D6\0K(,!!2M2T&BE@8P*N<ZU+33
M(&0?@Y!\7D1C0K5$'8?4PF>7QA8K0A&ED@T@H; -ROAAL-DCO.S[?% +)D'Z
MG*"@\P7QM3#0Y+3%!)='6?WF""FR%RK[9I"=6]_G]B;K/^*"N*/E)B>V%C.*
M?+9X66MN%Y"\@_$8-S'(Y-D*E?PRSTF/+S[2$;SH[UMK(T]A9)?-.B%"6DQ%
MA'AS="CL5+&A\\D\&7*J\T@'%'X$Z>/KW(9JPD]AY""E=5"VD]9-!<W1HG-7
MA4RN;>:Y&4#"</A/,,^]_,D+/H693$+KQ*3JB,LW=8&3ZZN*EAS#C+ B3FBW
ME& -':K-%7G83V&: #F6"#'[_58Z!446F'E2REL3#F80ZR]1=2%5GY4>I#'^
ML%3H(2G8Q/6'UC4H8X>17G^A 6,D[D$4+>+U)8[J,6EN7,6N*W.9;OU:%&55
MK;8_WT,H;8X1$(80!E[ @GCZP.<;-,"A@@)]4$4$CA.9[O].$6TDK38_QSHH
MYXF1M@\H$:@17KM\]"9>I**/DXGRK%\<7!$#?4+3.'!EQ]N31JDVDN)6P2AA
M*E1SRP8H_219$%H)%^TNIT%SE-8Z.FD%_QN"]#ZK.2HPT,QH0[P%'^A6G<OQ
M*&#*MVQT(55'FH,TINF0(@@FJ'/YV_AWM)&W.];HK(,RGAAI^(AB\=.2X2H:
M@VIFH=Q>L=69',;[G(JA5,UJ>]5>0:$)1H_DNZ4WX_X0S9L3>6$UC^C]5,9G
MCVM-M!&U_^)$KH-0UAJ#-PSO(D*G'+U/%%[8C(\P<QROM'<,<Z-KW3)49K1U
MSW CCE)UM)9OX)9AOK%0T3$CO-SR:8<OIAX?0SQ5$*+<7I&)3 [3%&S%D%"S
MVG2U5U!H@L$308\+4ASV^81R^2?1GP(T<;4._H-<M@[[M2R2NH@+-W# ZVR$
MTO[48&&"D[&L=Y$X4XSG*1 D9,EFS8Z,]8IO\DF6H+$7XB1YG P9>-\5O\4I
M'5^!E,*<QA\M"#UQ72 5;?]2I[RE4-DK2_3L%Z'\:5YQ8 U>CI/9!L7VS_9*
MV CE_2D'!Q]5EK+C[3?MKNRZ6/--W*40+VGRW -,_\+A@K3;[<Z T.$,4]);
M) RB!Z)X1E5W]PJ$5)4PSDU^*2BM!7U-J[''4^U6P*D>G\3>%TS%J^?)" ;<
M\!E.R%X=1>15WKDJ=Z4%C#]6RRND6>:J-P%.<_>0-_X-][[P/5]ZMUL5I/_1
M!U_S'U!+ P04    " "@30I7E+33S!,%  "P-   %0   &=O=G@M,C R,S X
M,#E?<')E+GAM;-U;76_B.!1]7VG_0S;[G(:/[6Y!PXP0[8S0TBDJS,YJ7RJ3
M&+#JQ,AV"OS[O38?0T6<F%9!@U\*V,?V\<FU?7UO^N'3*J'>"^:"L+3CUZ]J
MOH?3B,4DG77\;Z.@.^KU^[XG)$IC1%F*.W[*_$\??_WEPV]!\ 6GF".)8V^R
M]L;S+(TQOV4)]H:,2T2]P+L)6V&CUFAZU^UZLUV[]H;W0:!:4Y(^M]6?"1+8
M Q:IT#\[_ES*13L,E\OEU6K"Z17C,^BBU@QW:'\+5[6QW#<X!%^'F\H]]*CK
M95-CZZU6*]2U>Z@@>4#HM![^>S\817.<H("D2I)(<1&D+73A@$5(:AU+I^ 9
M$>I7L(,%JBBH-X)F_6HE8G\O'&<4/^*IISZ_/?9?C3AC+ZNKB"5:]]I-K14J
M5 A\)4YP*H.819G^ L\T@$\BUS"?*>.)I@]3TF/,.9YV?-5;L.M)D?C]Y([D
M>@%F(TBRH-@/]W-8<"R@D88.H&"+5F0KF<^&!EY)#&9ZH"5ET:L9JZ'%SIX$
MCA2!,,9$CZ^^:#FT%/#CZ4X/"%:/R'XHBB:8=GQ3]88)5>;"^($B[V0RP#-$
M-^-U5T3DD#$@*N)SNWTN_1_/8HPF%.<0*X.>CR%8(NZ#8>7)9P.OF.D8NB]@
M=EA=,9,AYH3%=VE\"^NP@%(NKB)N&]-^Q#,B)$>I_(J2/&I%L$J9]>%HY0O&
MM>F,U ;68UDJ^;K'8C-1JU:5\OY,*/Z:)1/,C22/(94R&J-5/U9[_91L#MT2
M>B7X2KEVXQB..K']4#M&W<BS 'L.CCWX^L#';&D^RHS(<_#3UO_ AYR]D(WW
M54C2 #\'TR$#!X7^1Q:%2[L(7!%+]>"Z'",#K[SJJOP5Z) .YW"I,"Y>$Z0B
M1M\YD> >]EB29.EVH\AS! IQ%7$;,4HB(N%B=@]&S0FB.<3,H(I8#3E6*L"=
M4?OB8^5;\X?I-/=IEH//P[(O1(;Y25R-3:IZVCC*P,C6]<9D3&2NSVR"5,1H
MS)&*"HS6R83EF5YN?<7JW*VB.4IGV.#G%<$J/0/N$LQG(,87SI9R#G:T0.G:
M> @4HBOBV06CCI5A?Z9HEL,LM[Y2S7HP&$>T#RML]3<VJV7 O8G;%(F)#KUD
M(I@AM-@0Q%2*7<D/IMN"I]$N[M"C2(B'Z4BRZ#GGOFV-/QOS0P*Y\8IRH"W7
MXZB1*GE2.ZJZPD"_0\3_033#M5JM#E?$T1S!AIL)R9)[G.,,O+7Y.PE_1UQ=
M$,68#3,.FXC !QS*Z)[<V$3V,%+6Y9''.)Q"';_F>U #9Q''\6 SKC&LJ$-F
MFAP,ID.C[8@R@>..+WFVWQ41CX[B;Z\[VB+"!0B>RB":$QKO6D\Y2XH#3:PL
M* ;=ET^\_G-.W'[%,_NU9B5(PP%!WK?"K61JNB+3&W>6G4B7NZ^4QHF91:#[
MDO<86Q%.]#XL+>,GW6=.L0S[&+Z5F5S66CF>*;.-B#NX:(QJF+,IEWP:OU6%
M@@3.)9^Z;ULB)^1BK,3YPR5Q3#D@*R6N75+"*MUD)<N?+LE2FMVRDN0O!R4Q
MI=.L!+EQ4)#"U)V5*BT'52E(%-HY:([XJ^8LI9T,CCBJQ>E1.RD<\58M4K)V
M>CCBKI9E@NW$<,0]M4T\VXGBB*=Z6H;;3AI'O-7BU+J=%(YXJ05I?3L=''%.
MR]\EL)/#*:_4XLT%NXB9(VYIP5L3=CHXXI=:O*EQD'$(CR2!CI\_[FO4'_7?
M,%#R/U!+ P04    " "@30I7A'-ZVN<0  "2:@  $P   &=O=G@R,#(S,#@P
M.5\X:RYH=&WM/6MSVSB2GR=5]Q]PVIM=NTJ4*,F.9=EQE2,_1A?'=DG>2>J^
M3$$D)&%,$0P 6M+^^NL&2(F4*3\2OV(G-8E-XM7O;C2:F-V1'@=D.@Y"]:$T
MTCIJ5:N3R:0R:52$'%9KV]O;U2GV*=E.+<D&N8[3O@Q,U[KKOJ]":]H1&WP^
M[YOO9QO3KB'EGLKW5,RK#,55U33!F'HC.R]?"4*CRD.E:>BQ>7_E%V$&?6O5
MKY]/>MZ(C6G:F4^U TOG!J2@\##@(?OZL7M2U9*&:B#DF&HN0IBKMNFX3:=1
MFR\*72]7$Q1;,TL68W/;>G6G_GY.01&&\;AX'E_+JIY%K J='.C%)/?2<;%R
ML&E!_ %5?3,J;<G1/M:2#5?2?KL*[0NT5O6K-3*H90"1(E@!B&E!0%S'K66H
MK'0DB\4&6W*07^-'7FBPN4_57&BX$AOUVM9-8F9[I . R$N4+.9!BD2]EM,3
M7:@GFU9/]$*4^>VB["PK@![%H<^D+\8L-[I[<'S$ ?&AJGABG&'QW1@\+308
MM\#B,U[,,&C(2YIRAI1&A>* #;G.GHA#+6?%,R>-N0%RA=A(%)I:<TG*N+="
MR+B7!R.6DH7>*CB2UMP0-O5&Q=VQ)==527V=&O RUPE&YO4.7R![32^WZ6Z7
M]G9'C/I[[W[;U5P'; ][I(U_-2\K8.QWJ[;IW6_0Z[\=AQRSD$FJF4_Z,W)A
MY>D Y(F<"ZEI0!S2K&Z;)<AFJU9O;6Z1\\_$<?;>[8Z9I@0!<MBWF%]]*+5%
MJ%FHG0M0AQ+Q[-.'DF937;6.IKJW6[4P[O:%/R-*SP(0W0%T=13_#VN1FAOI
M'6)>#.B8![,6^>>W6.B="SYFBIRR">F*,0WMRQT24=\'06\1EX?$K=1XN$.
M'TK(%J&Q%CM %9]?I2OY7$4!A4G!8K+2WG^]V^73%D+$9/K ?9^%R0/T.K5F
MU:(SU5UTDC[2H_FI1$**F@<2WMH?L]"'O_HHH,/2WH &BNU6<U/<>\[#$)@U
M:\.DD@8=X,ST$YN5]ESXTVS4-YK;UQ> ):K+2(#G9BB?3.$+M(<M9708UB7&
M8;5&QO>CO#BIP%3 NY:29K1O'TJ*CZ. (1.35?(3FQ=*Q#)Y-MZ\E:!(N+]
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M$!:(B$FZF 8 BP-M:J266A#V?JP@WE:**:L:8PKO&*'>MYC+:XI=(;V1B .
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ME]\,IM/#+PEB^+__V/M_4$L! A0#%     @ H$T*5P9_#Q$.*   6ED!  T
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4!08     !@ & (0!   I3P     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
